Jaume R. Mora

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 197 publications

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.

Journal: Nature medicine

Published: September 02, 2026

Quantum-Capacitance Biosensing Enables Real-Time Monitoring of Naxitamab for Therapeutic Response Stratification in Neuroblastoma.

Quantum-Capacitance Biosensing Enables Real-Time Monitoring of Naxitamab for Therapeutic Response Stratification in Neuroblastoma.

Journal: Small science

Published: April 07, 2026

Scaling-Up Research in Childhood Cancer in Low- and Middle-Income Countries.

Scaling-Up Research in Childhood Cancer in Low- and Middle-Income Countries.

Journal: Pediatric blood & cancer

Published: January 08, 2026

miRNA profiling in pediatric and young adult Burkitt leukemia and lymphoma.

miRNA profiling in pediatric and young adult Burkitt leukemia and lymphoma.

Journal: Virchows Archiv : an international journal of pathology

Published: November 06, 2025

Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.

Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 18, 2025

Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma.

Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma.

Journal: Neuro-oncology advances

Published: July 24, 2025

Idasanutlin in Combination with Chemotherapy or Venetoclax in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors (iMATRIX Idasa): Results of a Phase I/II, Multicenter, Multi-arm Study.

Idasanutlin in Combination with Chemotherapy or Venetoclax in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors (iMATRIX Idasa): Results of a Phase I/II, Multicenter, Multi-arm Study.

Journal: Targeted oncology

Published: July 04, 2025

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Journal: Molecular cancer therapeutics

Published: April 29, 2025

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio-Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse.

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio-Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse.

Journal: Pediatric blood & cancer

Published: April 27, 2025

Spatiotemporal T-cell tracking for personalized T-cell receptor T-cell therapy designs in childhood cancer.

Spatiotemporal T-cell tracking for personalized T-cell receptor T-cell therapy designs in childhood cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 18, 2025

Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas.

Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas.

Journal: Journal of neuro-oncology

Published: December 02, 2024

Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy.

Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy.

Journal: Frontiers in pediatrics

Published: October 11, 2024

Showing 1-12 of 197

Last Updated: 09/26/2026